Identification of a Prognostic Model Based on Immune Cell Signatures in Clear Cell Renal Cell Carcinoma

Figure 3

Evaluation of ICS score model. (a) Estimation of the OS in the training cohort. (b) Distribution curve in the training cohort. (c) Survival scatter diagram in the training cohort. (d) Estimation of the OS in the validation cohort. (e) Distribution curve in the validation cohort. (f) Survival scatter diagram in the validation cohort.

(a)

(b)

(c)

(d)

(e)

(f)